The GIFT Study – Will Genotype-Guided Dosing of Warfarin Catch On?

Free
0 Based on 0 Votes
  • 5
    0
  • 4
    0
  • 3
    0
  • 2
    0
  • 1
    0
Categories : Anticoagulation Therapy, Pharmacogenomics, Public, Therapeutics

Course Overview

The Genetics Informatics Trial (GIFT) examined the potential benefits of using genotype information to personalize the dosing of warfarin therapy in patients undergoing elective hip or knee replacement surgery.  Previous trials have not consistently shown that genotype-guided warfarin dosing is beneficial.  Dr. Paul Solinsky reviews the methods and results of the GIFT Trial and our panelists, Dr. Daniel Witt and Dr. Edith Nutescu, discuss the study implications.

 

Registration Fee:  Free but please give a tax-deductible contribution to the University of Mississippi Foundation to support iForumRx.org and keep programs like this available.  (Suggested donation $20)

Program UAN: 0032-0000-18-040-H01-P
Activity Type: Knowledge
Activity Length:  0.5 hour contact hour (CPE credit)
Release date:  June 1, 2018
Expiration date:  June 1, 2021

This program is intended for pharmacists who provide care to patients taking anticoagulation therapy.

 

The University of Mississippi School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

To successfully complete this program you must complete all of the modules in the course and achieve a passing score on the post-module quiz.

Click on the TAKE THIS COURSE link to register.

Course Materials

Before viewing the video of the GIFT Trial summary - please download a copy of the manuscript: Gage BF et al. JAMA 2017; 318 (12): 1115-1124. doi: 10.1001/jama.2017.11469